The mobster-in-therapy sequel Analyze That, starring Robert De Niro and Billy Crystal, had a weaker debut than the original movie, opening with $11.3 million.

BOND IS BACK

Die Another Day Returns to No.1

Die Another Day, which debuted as the No. 1 movie two weeks ago, returned to the top spot this weekend with $13 million.

The mobster-in-therapy sequel Analyze That, starring Robert De Niro and Billy Crystal, had a weaker debut than the original movie, opening with $11.3 million. Analyze This had premiered with $18.4 million in 1999 on its way to a total gross of $106.7 million.

Last weekend's top film, Harry Potter and the Chamber of Secrets, slipped to third place with $10 million, lifting its total to $213.9 million in just over three weeks.

John Leguizamo's drug and gangster drama Empire opened strongly in narrower release, grossing $6.3 million and coming in at No. 4. Playing in 867 theaters, Empire averaged a healthy $7,235 a cinema, compared with a $4,288 average in 2,635 theaters for Analyze That.

The sci-fi thriller Equilibrium, starring Christian Bale, Taye Diggs and Emily Watson, opened weakly with $528,000 in 301 theaters, averaging $1,754. And, Adaptation grossed $400,000 in just seven theaters for a whopping $57,143 average.

The overall box office was down, with the top 12 movies grossing $69.5 million, off 15% from the same weekend last year, when Ocean's 11 opened with a $38.1 million debut.

HITS LIST BLASTS OFF
Space is the place for Tay. (4/30a)
TAY RACKS UP STATS, OBLITERATES RECORDS
What did you expect? (4/30a)
STAGECOACH: THE FINAL DESERT EXCURSION
Our weary travelers reflect on their adventure. (4/30a)
BILLIE'S BACK WITH BIG WORLD TOUR
Promises to be a Hard ticket to score. (4/30a)
HIPGNOSIS BOARD APPROVES UPPED BLACKSTONE BID
But it ain't over till it's over. (4/29a)
THE NEW UMG
Gosh, we hope there are more press releases.
TIKTOK BANNED!
Unless the Senate manages to make this whole thing go away, that is.
THE NEW HUGE COUNTRY ACT
No, not that one.
TRUMP'S CAMPAIGN PLAYLIST
Now 100% unlicensed!
 Email

 First Name

 Last Name

 Company

 Country
CAPTCHA code
Captcha: (type the characters above)